We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.
- Authors
Dahut, William L; Gulley, James L; Arlen, Philip M; Liu, Yinong; Fedenko, Katherine M; Steinberg, Seth M; Wright, John J; Parnes, Howard; Chen, Clara C; Jones, Elizabeth; Parker, Catherine E; Linehan, W Marston; Figg, William D
- Abstract
Both docetaxel and thalidomide have demonstrated activity in androgen-independent prostate cancer (AIPC). We compared the efficacy of docetaxel to docetaxel plus thalidomide in patients with AIPC.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Vol 22, Issue 13, p2532
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2004.05.074